SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr. Forthright who wrote (626)5/9/1998 11:44:00 AM
From: SOROS  Read Replies (1) of 1185
 
Allen Bain, former President of Nortran Pharmaceuticals said in 1997:

"More significantly, this partnering strategy and execution will separate NRT management from their more promotion-oriented counterparts. There are dozens of examples of comparable companies who try to "sell the sizzle without the steak." To this extent, Nortran finds itself in a relatively unusual situation for a development stage pharmaceutical company - they have provided the foundation for solid drug development programs, have further legitimized their ownership, and are now grappling with the best manner in which to reach potential investors.

We are encouraged about the long term prospects for NRT in that they have hired of some "heavy hitters" to actively serve on both their Board of Directors and Scientific Advisors. In addition, they have hired a CRO to draft an appropriate clinical plan for NRT's second and third generation acute and chronic anti-arrhythmics, perhaps from which licensing negotiations for the compounds may commence.

In the coming months, we expect NRT to place a president and CEO who can manage the transition from a drug discovery company to one of partial drug development and negotiate at least one other significant outlicensing deal with a major pharmaceutical player."


SOROS note: Nortran has accomplished ALL of this already! This company is not a scam. It may have some promoters attached to it, but that is natural when a company has the kinds of prospects that Nortan has. I have no problem with keeping your eyes open in any investment and being aware of potential leeches, but to present only these few negative areas which may keep someone from investing in a great company is as big a disservice as selling someone on a bad company. Let's try to be balanced on this thread. I love to tell stories and entertain, but only when I put my money where my mouth is. This does not make me infallible, but at least honest. The above is an old bat-lover's opinion only. Please do your own DD.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext